TG Therapeutics (TGTX) News Today $31.15 +0.83 (+2.74%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Oppenheimer & Co. Inc. Takes Position in TG Therapeutics, Inc. (NASDAQ:TGTX)Oppenheimer & Co. Inc. bought a new position in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 32,470 shares of the biopharmaceutical company's stock, valued at approximately $759,000. A nuNovember 20 at 3:31 AM | marketbeat.comState of New Jersey Common Pension Fund D Decreases Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX)State of New Jersey Common Pension Fund D lowered its stake in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 27.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 82,752 shares of the biopharmaceutiNovember 18 at 3:42 AM | marketbeat.comEntropy Technologies LP Takes $730,000 Position in TG Therapeutics, Inc. (NASDAQ:TGTX)Entropy Technologies LP acquired a new position in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 31,200 shares of the biopharmaceutical company's stock, valued aNovember 15, 2024 | marketbeat.comTG Therapeutics, Inc. (NASDAQ:TGTX) Stake Boosted by Principal Financial Group Inc.Principal Financial Group Inc. lifted its stake in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 1,549.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 772,188 shares of the biopharmaceutical company's stocNovember 15, 2024 | marketbeat.comAmalgamated Bank Has $925,000 Stake in TG Therapeutics, Inc. (NASDAQ:TGTX)Amalgamated Bank lifted its position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 712.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 39,528 shares of the biopharmaceutical company's stock aftNovember 15, 2024 | marketbeat.comReporters tweets about ‘vague whispers’ of bid interest in TG TherapeuticsNovember 14, 2024 | markets.businessinsider.comTG Therapeutics, Inc. (NASDAQ:TGTX) Director Sells $152,200.00 in StockNovember 13, 2024 | insidertrades.comLos Angeles Capital Management LLC Has $2.89 Million Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX)Los Angeles Capital Management LLC increased its position in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 33.7% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 123,401 shares of the biopharmaceutical company's stock after purchasing an additional 3November 13, 2024 | marketbeat.comInsider Sale: Director Sagar Lonial Sells 5,000 Shares of TG Therapeutics Inc (TGTX)November 12, 2024 | gurufocus.comInsider Sale: Director Laurence Charney Sells 25,000 Shares of TG Therapeutics Inc (TGTX)November 12, 2024 | gurufocus.comNew York State Teachers Retirement System Purchases Shares of 42,927 TG Therapeutics, Inc. (NASDAQ:TGTX)New York State Teachers Retirement System acquired a new position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 42,927 shares of the biopharmaceutical company's stock, vNovember 10, 2024 | marketbeat.comFY2024 EPS Estimate for TG Therapeutics Raised by AnalystTG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) - Cantor Fitzgerald raised their FY2024 earnings per share estimates for TG Therapeutics in a report released on Tuesday, November 5th. Cantor Fitzgerald analyst P. Agrawal now expects that the biopharmaceutical company will post earnings of $0.10November 8, 2024 | marketbeat.comTG Therapeutics (NASDAQ:TGTX) Hits New 12-Month High - Here's WhyTG Therapeutics (NASDAQ:TGTX) Reaches New 52-Week High - Should You Buy?November 7, 2024 | marketbeat.comTG Therapeutics, Inc. Just Missed Earnings - But Analysts Have Updated Their ModelsNovember 7, 2024 | finance.yahoo.comB. Riley Lowers Earnings Estimates for TG TherapeuticsTG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) - Equities researchers at B. Riley reduced their FY2027 EPS estimates for shares of TG Therapeutics in a research report issued on Monday, November 4th. B. Riley analyst M. Mamtani now anticipates that the biopharmaceutical company will earn $2.46November 7, 2024 | marketbeat.comHC Wainwright Forecasts TG Therapeutics FY2024 EarningsTG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) - Research analysts at HC Wainwright reduced their FY2024 earnings per share estimates for shares of TG Therapeutics in a report issued on Monday, November 4th. HC Wainwright analyst E. White now forecasts that the biopharmaceutical company will eNovember 7, 2024 | marketbeat.comQ3 2024 TG Therapeutics Inc Earnings CallNovember 6, 2024 | finance.yahoo.comTG Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsNovember 6, 2024 | uk.finance.yahoo.comTG Therapeutics: Promising Growth Trajectory and Blockbuster Potential Justify Buy RatingNovember 6, 2024 | markets.businessinsider.comQ4 EPS Estimates for TG Therapeutics Raised by HC WainwrightTG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) - Research analysts at HC Wainwright increased their Q4 2024 earnings estimates for shares of TG Therapeutics in a report released on Monday, November 4th. HC Wainwright analyst E. White now forecasts that the biopharmaceutical company will post eNovember 6, 2024 | marketbeat.comFY2024 EPS Estimates for TG Therapeutics Cut by B. RileyTG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) - Analysts at B. Riley decreased their FY2024 earnings per share estimates for TG Therapeutics in a research report issued on Monday, November 4th. B. Riley analyst M. Mamtani now expects that the biopharmaceutical company will post earnings of $0November 6, 2024 | marketbeat.comTG Therapeutics: Strong Financial Performance and Strategic Expansion Drive Buy RatingNovember 6, 2024 | markets.businessinsider.comTG Therapeutics price target raised to $45 from $43 at LadenburgNovember 6, 2024 | markets.businessinsider.comTG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...November 6, 2024 | finance.yahoo.comTG Therapeutics, Inc. (NASDAQ:TGTX) Q3 2024 Earnings Call TranscriptNovember 6, 2024 | msn.comTG Therapeutics: Modest Q3 Sales Beat, Focus Shifts To Early 2025 UpdatesNovember 5, 2024 | seekingalpha.comTG Therapeutics (NASDAQ:TGTX) Stock Price Expected to Rise, HC Wainwright Analyst SaysHC Wainwright raised their price objective on shares of TG Therapeutics from $49.00 to $55.00 and gave the company a "buy" rating in a research report on Tuesday.November 5, 2024 | marketbeat.comTG Therapeutics (NASDAQ:TGTX) Given New $22.00 Price Target at The Goldman Sachs GroupThe Goldman Sachs Group lifted their price objective on TG Therapeutics from $20.00 to $22.00 and gave the stock a "neutral" rating in a report on Tuesday.November 5, 2024 | marketbeat.comTG Therapeutics (NASDAQ:TGTX) Announces Earnings ResultsTG Therapeutics (NASDAQ:TGTX - Get Free Report) issued its quarterly earnings results on Monday. The biopharmaceutical company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.02). The firm had revenue of $83.90 million during the quarter, compared to analysts' expectations of $81.68 million. TG Therapeutics had a net margin of 27.60% and a return on equity of 57.73%. The firm's revenue was down 49.4% compared to the same quarter last year. During the same quarter last year, the company posted $0.73 EPS.November 5, 2024 | marketbeat.comTG Therapeutics Posts Strong Q3 Briumvi Revenue, Here's Why Shares FellNovember 4, 2024 | seekingalpha.comTG Therapeutics: Briumvi Revenue SoarsNovember 4, 2024 | fool.comTG Therapeutics reports Q3 EPS 2c, consensus 3cNovember 4, 2024 | markets.businessinsider.comTG Therapeutics, Inc. (TGTX) Q3 2024 Earnings Call TranscriptNovember 4, 2024 | seekingalpha.comTG Therapeutics (NASDAQ:TGTX) Shares Gap Down - Here's What HappenedTG Therapeutics (NASDAQ:TGTX) Shares Gap Down - Here's What HappenedNovember 4, 2024 | marketbeat.comFUJIFILM Diosynth Biotechnologies Signs Manufacturing Supply Agreement with TG TherapeuticsNovember 4, 2024 | globenewswire.comTG Therapeutics, Inc. (NASDAQ:TGTX) Stock Holdings Increased by Raymond James & AssociatesRaymond James & Associates increased its holdings in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 35.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 170,160 shares of the biopharmaceuticalNovember 4, 2024 | marketbeat.comState of Alaska Department of Revenue Makes New $1.78 Million Investment in TG Therapeutics, Inc. (NASDAQ:TGTX)State of Alaska Department of Revenue acquired a new stake in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 76,130 shares of the biopharmaceutical coNovember 3, 2024 | marketbeat.comTG Therapeutics (TGTX) Set to Announce Quarterly Earnings on MondayTG Therapeutics (NASDAQ:TGTX) will be releasing earnings before the market opens on Monday, November 4, Zacks reports.November 2, 2024 | marketbeat.comTG Therapeutics (NASDAQ:TGTX) Hits New 1-Year High - Should You Buy?TG Therapeutics (NASDAQ:TGTX) Hits New 12-Month High - What's Next?November 1, 2024 | marketbeat.comTG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business UpdateNovember 1, 2024 | globenewswire.comLouisiana State Employees Retirement System Takes Position in TG Therapeutics, Inc. (NASDAQ:TGTX)Louisiana State Employees Retirement System acquired a new position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 64,500 shares of the biopNovember 1, 2024 | marketbeat.comIs TG Therapeutics, Inc. (TGTX) Set to Explode in 2025?October 31, 2024 | msn.comTG Therapeutics shares get Buy rating from TD CowenOctober 31, 2024 | uk.investing.comTG Therapeutics, Inc. (NASDAQ:TGTX) Receives Consensus Recommendation of "Moderate Buy" from AnalystsShares of TG Therapeutics, Inc. (NASDAQ:TGTX - Get Free Report) have earned an average rating of "Moderate Buy" from the seven ratings firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the comOctober 31, 2024 | marketbeat.comTG Therapeutics initiated with a Buy at TD CowenOctober 30, 2024 | markets.businessinsider.comThe Analyst Verdict: TG Therapeutics In The Eyes Of 5 ExpertsOctober 30, 2024 | benzinga.comTD Cowen Initiates Coverage of TG Therapeutics (TGTX) with Buy RecommendationOctober 30, 2024 | msn.comAssenagon Asset Management S.A. Sells 318,709 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX)Assenagon Asset Management S.A. decreased its stake in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 65.2% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 170,234 shares of the biopharmaceutical company's stock after selling 3October 30, 2024 | marketbeat.comTG Therapeutics (NASDAQ:TGTX) Shares Gap Up - What's Next?TG Therapeutics (NASDAQ:TGTX) Shares Gap Up - Time to Buy?October 29, 2024 | marketbeat.comTG Therapeutics (NASDAQ:TGTX) Now Covered by TD CowenTD Cowen initiated coverage on shares of TG Therapeutics in a research report on Tuesday. They issued a "buy" rating and a $50.00 price objective for the company.October 29, 2024 | marketbeat.com Get TG Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TGTX and its competitors with MarketBeat's FREE daily newsletter. Email Address [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin TGTX Media Mentions By Week TGTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TGTX News Sentiment▼1.260.45▲Average Medical News Sentiment TGTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TGTX Articles This Week▼65▲TGTX Articles Average Week Get TG Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TGTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Deciphera Pharmaceuticals News Sage Therapeutics News FibroGen News Insmed News Teva Pharmaceutical Industries News BeiGene News Viatris News Summit Therapeutics News Moderna News Genmab A/S News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TGTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TG Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TG Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TGTX Stock Alerts